Press Release | NeoGenomics Laboratories

April 27, 2016

NeoGenomics Reports 159% Revenue growth to $59.7 Million and 442% Adjusted EBITDA increase to $8.2 Million, Driven by Clarient acquisition and Strong Volume Gains

April 11, 2016

NeoGenomics Schedules its Q1 2016 Earnings Release for April 27, 2016

March 1, 2016

NeoGenomics Reports Record Revenue of $27.2 Million and Record Adjusted EBITDA of $2.9 Million in Fourth Quarter, Driven by Strong Volume Gains

January 26, 2016

NeoGenomics Schedules its Q4 2015 and Full Year 2015 Earnings Release for March 1, 2016

December 30, 2015

NeoGenomics Completes Acquisition of Clarient, Inc.

December 8, 2015

NeoGenomics Launches New Liquid Biopsy Tests for Monitoring Solid Tumors and Predicting Resistance to BTK Inhibitors

October 29, 2015

NeoGenomics Reports Revenue of $25.1 Million and Record Adjusted EBITDA of $2.8 Million Driven by a 25% Increase in Test Volume in the Third Quarter of 2015

October 28, 2015

NeoGenomics Amends Strategic Alliance Agreement with Covance Central Laboratory Services

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients